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Frameshift mutations provide recognized mechanisms for changing the coding potential of an organism.
Here, multiple frameshifts are identified in repetitive sequences within an Epstein-Barr virus unspliced early
gene, LF3, which is associated with the viral replicative cycle and also transcriptionally expressed in many
virally associated tumors. On the DNA strand encoding LF3, there are three open reading frames, only one of
which contains an initiation codon. Most (>95%) of the gene consists of numerous (>20, varying with cell
source) GC-rich copies of a 102-bp direct repeat (called IR 4) flanked by small unique sequences. LF3 may
express a protein if its initiation and termination codons reside in the same reading frame, but this is not
always the case. Frameshifting events, occurring in short runs of pyrimidines (mainly C residues) in the
repeats, give rise to mutations which may provide a mechanism for escape of an LF3 function from host
surveillance. Sequence studies link these frameshifts to DNA replication errors. Notably, the number of sites
in LF3 at which such mutations can occur permits a very large amount of diversity in this gene. Our data also
suggest a second degeneracy mechanism within the protein itself, which influences its stability and may reflect
a host defense mechanism. LF3 thus provides a potentially important model for studying the quest for
supremacy between a virus and its host.
Epstein-Barr virus (EBV), a human herpesvirus, is associ-
ated with a variety of human cancers as well as being a caus-
ative agent for infectious mononucleosis. Its genome (170 to
200 kbp) is characterized by unique DNA sequences inter-
rupted by tandem repetitive sequences, internal repeats (IR) 1
to 4, and terminal repeats (TR). The repeats themselves are of
various sizes, ranging from about 100 to 3,000 bp, but all
reside within genes. Three of these repetitive elements (called
IR 1, IR 3, and TR, respectively) are found in latent viral
proteins, EBV nuclear antigens 5 and 1, and LMP2A and -B
(membrane proteins). The other two repetitive elements, IR 2
(or NotI repeats) and IR 4 (PstI repeats), lie within genes that
have been classified as expressing early (replication-associat-
ed) functions (23, 30). The corresponding transcripts, called
BHLF1 (BamHI H leftward reading frame 1) and LF3 (left-
ward reading frame 3), are found in the polyribosomal fraction
of EBV-infected cells and represent the most abundant viral
transcripts synthesized during the EBV lytic cycle (5, 11, 15, 17,
30). Their open reading frames are almost entirely composed
of the repetitive elements. Structurally, there are similarities
between IR 2- and IR 4-containing genes, and both lie adjacent
to viral origins of lytic replication (13). Their protein products,
however, have different sequences, and antibodies to one do
not cross-react with the other (28, 29).
Although EBV IRs resemble in size the short interspersed
elements found in eukaryotic genomes, whereas short inter-
spersed elements are generally noncoding and can act as ret-
rotransposons, there is no evidence for retrotransposition of
the EBV tandem repeats. They appear to remain physically as
stable components of their respective viral genes. Nonetheless,
like chromosomal repetitive elements in general (21), by of-
fering the possibility of template-primer misalignments or gen-
eration of template hairpin structures during replication, the
viral repeats provide opportunities for replication infidelity or
transcriptional variation and mutations. Such events are pos-
tulated as relevant to viral evolution (14, 24, 41).
A remarkable feature of any microbial or mammalian cell is
the incredible accuracy achieved in maintaining the fidelity of
its genetic information. However, sequence alterations can and
do occur due to RNA/DNA polymerase slippages during tran-
scription or replication. In the RNA virus field, products have
been observed with genetic alterations associated either with
RNA polymerase slippages at tandem repetitive sequences or
mRNA editing that produces frameshifts within a single open
reading frame. Such mechanisms lead both to nucleotide de-
letions and insertions of G residues in paramyxoviruses (4, 16)
or, in bovine parainfluenza virus 3, to the expression of all
three reading frames in its P gene (32). An RNA polymerase
stuttering or slippage model has been proposed to explain such
events (40).
In the retrovirus field, infidelity of the reverse transcriptase
frequently results in mutation events, many of which appear
nonrandom (2). Further, many retroviruses use translational
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frameshifting on the ribosome at stem-loop structures for gen-
erating their pol gene products (31). In both Escherichia coli
and Thermus thermophilus, frameshifting events at runs of A
residues allow two components of DNA polymerase III to be
expressed from a single gene. In the latter case, this mechanism
has been attributed to slippage on the ribosome during trans-
lation (46), whereas in E. coli, the data suggest that the frame-
shifting has occurred during transcription (22).
In the DNA virus field, the fidelity of individual DNA rep-
lication complexes, whether mainly of cellular or mixed viral
and cellular origin, is sufficiently high that records of polymer-
ase slippages and frameshift alterations are rare. To expand or
alter their limited coding potential, DNA viruses mainly ap-
pear to rely on the use of multiple, alternative splicing sites for
processing transcripts that then allow different proteins to be
expressed from a single gene, as observed, for example, with
papovaviruses and adenoviruses. A classical case of infidelity,
however, in the DNA virus field involves the lysozyme gene of
bacteriophage T4. This has been attributed to stuttering of a
replication complex at short runs of A residues at two sites in
the gene (38). Polymerase slippages that alter mini- and mic-
rosatellite sequences in DNA are also well documented (6)
and, as seen with the RAD50 gene in colorectal cancer and
gastric carcinomas, may be related to tumorigenesis (19). Else-
where, sequence slippages have been reported in clinical iso-
lates involving herpes simplex virus type 2 (25).
Our attention became focused on slippage/frameshifting
phenomena while studying the EBV LF3 (IR 4-containing)
major transcript in virally associated cell lines and tumors,
where alterations possibly explainable by such mechanisms ap-
peared to occur (43). The literature on LF3 already pointed to
sequence variations which, if accurate, could best be explained
by the occurrence of mutation events (5, 11, 23, 30). A cartoon
based in part on literature data is shown (Fig. 1). Further
evidence for genetic diversity came from studying cell lines
derived from a Burkitt’s lymphoma patient, Daudi, which dif-
fered in their responsiveness to interferon alpha (12) as well as
in their abilities to express a protein from the LF3 gene (44).
These intriguing data led us to examine further the question
of frameshifting with regard to LF3 in other viral cell lines and
in primary tumors. Here, we describe stuttering or frameshift-
ing events as a general property of the LF3 gene. We show that
these events occur at the DNA level, that the altered sequences
are conserved within the viral transcript, and that they signif-
icantly affect protein synthesis, structure, and stability. We
suggest that the EBV LF3 gene may undergo frameshifts to
accommodate and evade the immunological profile of its host
while at the same time host mechanisms may be invoked to
degrade the respective viral protein. As such, the data illustrate
and in part define a hitherto unrecognized subtlety that exists
between EBV and its host cell.
MATERIALS AND METHODS
Cell lines and cultivation. B95-8, M-ABA, and M81 are cell lines immortalized
with EBV from infectious mononucleosis (B95-8) or nasopharyngeal carcinoma
(NPC) patients (M-ABA and M81). Raji, Daudi-ICRF, and mutant 100K (36)
(from Ian Kerr, Imperial Cancer Research Fund), and Daudi-ATCC, P3HR-1,
and BL74 are Burkitt’s lymphoma-derived cell lines. Ramos is an EBV-negative
Burkitt’s lymphoma line. The origin of several Daudi cell lines is described
elsewhere (20). All B cells were cultured in suspension in RPMI 1640 medium
with 10% fetal calf serum under standard conditions. They could be induced to
activate gene expression or produce virus as described previously (11).
Tumor materials. North African NPC xenografts (C15, C17, and C18, from
Pierre Busson) were maintained by propagation in nude mice (3). Primary
Chinese NPC biopsies were obtained from Hong Kong, and Burkitt’s lymphoma
biopsies were obtained from Blantyre, Malawi. Southern blot data showed all
tumors to be EBV positive.
RNA and DNA isolation for amplification protocols and sequencing. Total
RNA was isolated as a pellet from xenografts, cell lines, and fresh biopsy spec-
imens by the guanidinium-cesium chloride method, as described previously (43),
and polyadenylated RNA was selected on oligo(dT) mRNA purification columns
(Pharmacia). Polyadenylated RNA (1 g) or total RNA (5 g) was treated with
10 U of DNase I (Boehringer) to remove any DNA in the RNA samples. DNA
isolated from the supernatant of the total RNA preparation by standard proce-
dures was used as a control for DNase I digests or as a substrate for PCR
amplifications.
DNA sequencing. PCR products were either sequenced directly from gel-
isolated materials or cloned into a pBIISK vector (Stratagen) or M13mp19 and
then sequenced with the ABI Prism dye terminator cycle sequencing kit as
specified by the manufacturer (Applied Biosystems Inc.).
cDNA synthesis, RT-PCR, and PCR amplifications. To obtain the 5-end
sequence of the LF3 transcripts from different EBV strains and tumor biopsies,
DNase I-treated RNAs (1 g of polyadenylated RNA or 5 g of total RNA)
were used for first-strand cDNA synthesis with a gene-specific primer, 5-CTG
CAGCCGGGTCCGGGGTT-3 (EBV nucleotides 3470 to 3489) (30). Synthe-
sized cDNA was diluted (to 100 l) in l0 mM Tris-HCl (pH 8.0)–0.1 mM EDTA.
PCR amplifications were carried out on 5 l of cDNA over 36 cycles with
5-GGTCCGGGGTTCCGGCCCTG-3 (3479 to 3498) and 5-CGCTCGGGG
GGTGCACACCT-3 (3684 to 3665) as primers, as described previously (43).
Products were separated by electrophoresis on 1% agarose, and identities were
FIG. 1. Schematic diagram of the structure of the LF3 early gene from EBV (not to scale). Within the LF3 coding region on the viral genome
there are three open reading frames, only one with an initiation codon (ATG), and several termination codons, all in the same reading frame (see
Fig. 2), the first of which (TGA) is shown. LF3 encodes an unspliced transcript with a single polyadenylation (AATAAA) signal. The gene has short
unique sequences at its 3 and 5 ends (indicated by heavy solid lines) and contains numerous copies of 102-bp repeats (IR 4), as indicated. Within
each repeat lie pyrimidine-rich sequences (two sets of which, at the 5 and 3 ends, are given) that are subject to frameshifting events during DNA
replication, producing mutations, as noted. The number of repeats may vary (as indicated) according to the cell source, as do the oligopyrimidine
sequences, and, depending upon the sequences at the latter slippage-prone regions, initiation and termination codons may or may not lie in the
same reading frame.
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verified by Southern blot hybridization and DNA sequencing. PCR amplification
of DNA for sequencing purposes used the same primers and conditions as for
cDNA.
RACE analysis. For 3 end sequence determination on LF3 transcripts, the
rapid amplification of cDNA ends (RACE) protocol (9) was employed. mRNA
(1 g) was primed with 5-GACTCGAGTCGACATCGATTTTTTTTTTTTTT
TTT-3 and reversibly transcribed with Moloney murine leukemia virus reverse
transcriptase (Gibco-BRL). cDNA was amplified by PCR with a gene-specific
primer, 5-CCCGAGCTCCAGGGCCGGAA-3 (1161 to 1142), and an adapter
primer, 5-GACTCGAGTCGACATCG-3. Positive bands, identified by South-
ern blotting, were subcloned and sequenced.
Determination of IR 4 repeat copy numbers from cell lines and tumor biop-
sies. Total chromosomal DNA, digested with BanI and DdeI, was separated by
electrophoresis on a 1% agarose gel, transferred to nylon membranes, and
hybridized with a 32P-labeled PstI fragment from Daudi cells (11). Product
migration, relative to size markers, allowed copy numbers to be derived. Raji
DNA, giving a fragment 2.5 kbp in size, with 24.7 copies of the repeat (30), served
as an added control for this experiment; 0.7 of a repeat unit lacks a PstI site.
IR 4 repeat studies. To obtain the sequence of the internal 102-bp repeat
region, high-fidelity PCR was performed with primers 5-CCCGAGCTCGAGG
GCCGGAA-3 and 5-CTGCAGCCGGATCCGGGGTT-3 (italic sequences
are restriction enzyme sites used in cloning of the DNA products). PCR utilized
heat-denatured total cellular DNA (1 g) from uninduced or chemically induced
Daudi-ICRF cells, 400 ng of each primer, 0.1 mM each of the deoxynucleoside
triphosphates, and 2 U of HiFidelity DNA polymerase mix (ABgene). Amplifi-
cation involved an initial denaturation at 95°C for 5 min, followed by 40 cycles of
30 s at 95°C, 20 s at 60°C, and 40 s at 72°C. PCR products were digested with
XhoI and BamHI restriction enzymes and cloned into M13mp19. Representative
clones were sequenced with dye terminators.
Generation of antipolypeptide antisera. Peptides from the three coding frames
in the IR 4 repeat region were used: PP, H2N-PPPERGSGPSGPGGP
PGRPPSSRAGTPDPAAAGH-COOH; PR, H2N-PRRSGAADPADPVGH
PAAPRAPGPEPRTRLQPAT-COOH; and PA, H2N-PAGAGQRTQRTR
WATRPPPELQGRNPGPGGSRPP-COOH. They were synthesized with a
433A solid-phase synthesizer (Applied Biosystems Inc., Poster City, Calif.). Pep-
tide-keyhole limpet hemocyanin conjugates were emulsified at l mg/ml in
Freund’s complete adjuvant, and 2 ml was injected subcutaneously into New
Zealand White rabbits. At 4 weeks, a second immunization was given with
peptide-keyhole limpet hemocyanin in Freund’s incomplete adjuvant. Immuni-
zation was repeated until a strong antibody titer (l:1,000, checked by peptide
enzyme-linked immunosorbent assay [ELISA]) was reached, and then the rabbits
were bled. The resulting serum samples and preimmunization serum samples
were checked for specificity and reactivity by peptide ELISA and immunoblot
staining with chemically induced HH514 (P3HR-1-derived) cell extracts as de-
scribed previously (27). No cross-reaction by ELISA was observed with antipep-
tide sera on the individual (see above) peptides.
Protein extraction and Western blotting analyses. Confluent cells (30 ml),
treated or not treated with chemical inducing agents (tetradecanoyl phorbol
acetate and n-butyrate) (11), were harvested and pelleted. After three washes
with ice-cold phosphate-buffered saline, cell pellets were resuspended in 0.6 ml
of cytolysis buffer [20 mM Tris-HCl (pH 7.6), 50 mM KCl, 400 mM NaCl, 150
mM 2-mercaptoethanol, 1% (vol/vol) Triton X-100, and 20% glycerol]. Lysates
were incubated on ice (20 min) and spun at 4°C (12 min), and supernatant
containing cytoplasmic protein was transferred to a clean 1.5-ml microfuge tube
and stored at 70°C prior to use. In all cases, samples from 2  106 cells were
loaded for electrophoresis purposes. Western blots were performed as described
previously (29).
Immunofluorescence analyses. Healthy proliferating cells, with or without
chemical induction, were pelleted, washed with ice-cold phosphate-buffered sa-
line, and resuspended (in phosphate-buffered saline) to 2  106 cells/ml, and 20
l was dropped onto glass slides coated with 3-aminopropyltriethoxysilane over
an area of about 1 cm in diameter, dried at room temperature, and stored at
70°C (26). Cells were fixed with 4% paraformaldehyde (10 min) and blocked
with 10% normal swine serum (20 min) and then incubated with rabbit anti-LF3
antibody (1:50 dilution) (29) or preimmune serum for 1 h. Cells were incubated
with biotinylated swine anti-rabbit immunoglobulin (1:500 dilution; Dako) for 45
min, followed by Texas Red-conjugated streptavidin (1:200 dilution; Amersham)
for 45 min. All antisera were diluted in 3% bovine serum albumin (Sigma) in
phosphate-buffered saline, and intervening washes of slides were carried out
twice with phosphate-buffered saline for 5 min. Cells were counterstained with
4,6-diamidino-2-phenylindole (DAPI) and examined under a fluorescent mi-
croscope (Zeiss Axiophot).
RESULTS
Sequence variations at the 5 and 3 ends of LF3 occur
initially at the DNA level and produce frameshift alterations.
LF3 is a highly structured GC-rich gene containing numerous
102-bp (34-amino-acid) repetitive (IR 4) sequences (Fig. 1). In
its open reading frame, after a short (59 nucleotide) unique 5
sequence, a repetitive region is encountered. Each repeat con-
tains short runs of pyrimidines (mainly C residues), which,
depending upon the source of the gene, have been reported to
be TC3 (from M-ABA cells [1]), TC4 (from Raji and Daudi
cells [references 30 and 11, respectively]), and C6 (from an
NPC xenograft, C15 [43]). At the 3 end of the gene, within the
repetitive sequence, a similar run of oligopyrimidines exists,
described as C5 in M-ABA and Raji cells, as C6 in Daudi cells
and the C15 tumor, and as C7 in AG-876 B cells (5; the 5
sequence was not reported in that paper). Notably, 95% of
the gene is composed of repetitive sequence. The net result of
the reported variations, assuming a constant 102-bp repeat, is
that only in M-ABA cells does the sequence of LF3 include a
classical open reading frame, where in-frame initiation and
termination codons are encountered prior to a polyadenylation
AATAAA (transcription maturation) signal in the gene. Tran-
scripts of LF3 are not spliced but are linearly related to the
DNA.
We began our studies by examining in greater detail the
apparent frameshift mutations at the 5 and 3 ends of the LF3
gene, asking whether the sequence variations observed in cell
lines such as those described above are reflected in the gene
from primary EBV-associated tumors, whether sequence dif-
ferences are tumor type specific, whether mechanistically the
frameshifts have occurred during DNA replication or tran-
scription (within a particular cell line or tumor), and how much
diversity is observed. DNA (by PCR) and RNA (by RT-PCR)
sequences over both 5 and 3 apparent frameshift variable
regions were determined. Sequence data from relevant regions
of the LF3 gene were obtained from both virus producer
(P3HR-1 and BL74) and nonproducer (Raji, Daudi-ATCC,
Daudi-ICRF, and 100K) human cell lines, from North Africa
NPC xenografts (C15, C17, and C18), and from primary biop-
sies, two from Asian NPC tumors (NPC 1 and 2) and nine
(BL001 to BL007, SD, and IB) from Malawian African Bur-
kitt’s lymphomas. Similar data were also obtained from a mar-
moset cell line, M81.
DNA sequence studies showed the unique regions of LF3 to
contain invariable sequence. On the other hand, as given in
Table 1, runs of pyrimidines at the 5 end of the gene were
variously found to be either C6, TC4, or TC3, and at the 3 end,
either C6 or C5. From a single source, the sequence data
obtained on the mRNAs were identical with the DNA data.
There appear to be two discrete patterns among the lympho-
mas and two among the NPCs, which overlap but are not
entirely identical. However, the data are too limited to attach
any significance to these results at present.
Figure 2, given as a DNA sequence, corresponds to LF3
transcripts and predicted translation products from different
cell sources (see Table 1), up to and including the poly(A) tail.
It assumes that the repeats are 102 bp, as reported (11, 23, 30,
43), and that the first polyadenylation signal encountered in
the sequence is used for the production of mature polyadenyl-
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ated LF3 mRNA (43), as was subsequently found (see below).
Thus, only sequence pattern combinations from 5 and 3
frameshifts that produce number combinations divisible by 3
(that is, n  12 and 9, Table 1) should specify proteins. The
combinations uncovered in this work are defined in Table 1 as
patterns 1 to 6, where, as illustrated in Fig. 2, only 1 or 6 is
predicted to generate a protein. In published studies on the
LF3 translation products (29), proteins were observed with
P3HR-1 and M-ABA cells, as predicted. A protein was also
detected in BL74 tumor cells, which was not predicted on the
sequence evidence presented here.
RACE analyses show invariant 3 ends for LF3 transcripts.
In the model that describes the LF3 open reading frame and
frameshift effects (Fig. 2), it is assumed that the first
AAUAAA in the transcript is used as the polyadenylation
maturation signal for the RNA. In the case of Raji cells, al-
though no protein was identified, it was suggested (30) that
readthrough to the next polyadenylation signal containing an
in-frame termination codon might occur to produce a protein.
Since such a mechanism might allow a protein product to be
made from other open reading frames in this region of the
EBV genome, a RACE protocol (9) was used to determine the
3 ends of LF3 transcripts in the cell lines and tumors studied
here.
In every case examined (data not given), including Raji, with
a ubiquitous internal sequence primer, the same-sized product
was obtained, indicating that LF3 transcripts all terminate at
the same position as that shown in Fig. 2. Sequencing of RACE
products also showed that the first AAUAAA polyadenylation
signal in the transcript, as noted, was used in every case and
identified the poly(A) tail position shown. Thus, based on the
two assumptions cited, were an LF3 protein identified in ma-
terials cited in patterns 2 to 5, as for example, in the case of
BL74 cells (Table 1), mechanisms other than frameshifting
events at the ends of the repetitive regions are necessary to
permit protein expression.
Frameshifts in internal IR 4 repeats also occur to produce
genetic variations. It is generally assumed from sequence evi-
dence that although point mutations may occur within the
repeats in LF3 from different cell types, the size (102 bp) of the
repetitive element is invariant (11, 23, 30, 43). There is, how-
ever, a single report of a 103-bp repeat (in AG876 B cells),
involving expansion of a frequently observed C6 sequence to
C7 (5), which alters the coding frame. The question of internal
repeat variability could be addressed in detail were it possible
to sequence across the repetitive elements, but this has to date
defeated all attempts both by us and by others. This is probably
due to the GC-rich (85%) repetitive element; in the LF3
transcript, this folds into a predictably highly stable secondary
structure and behaves like a double-stranded RNA in enzy-
matic digests (12).
To explore this question, we adopted a cloning methodology
previously used to search for DNA fidelity during replication
(35). For this, we used cellular DNA from chemically induced
or uninduced Daudi-ICRF cells as the work of others sug-
gested that protein synthesis might require chemical inducing
agents (29). Daudi-ICRF cells were chosen because prelimi-
nary data suggested that a protein could be produced in this
cell line (44), although none had been predicted from simple
sequence data (Table 1 and Fig. 2), nor was one detectable in
another Daudi line, Daudi-ATCC (11). Of relevance, Daudi
lines need not be identical. Historically, whereas their precise
origins remain obscure, their natural history allows variation
(20); four separate lines were produced over time from the
tumor patient Daudi prior to and after chemotherapeutic re-
sponse, followed by tumor relapse.
In our present study, PCR primers were chosen that should
produce products which, when cloned into suitable M13 vec-
tors, would yield blue plaques from a 102-bp repeat unit and
white plaques from 101- or 103-bp repeats. For amplification,
the Extensor Hi-Fidelity PCR enzyme (ABgene) was used be-
cause of its low error rate, in the range of 5 105 to 3 106
errors/base, depending on the nature of the template (infor-
mation from the manufacturers). We obtained both blue and
white plaques. Cloned DNA products were sequenced. Diffi-
culties in designing suitable primers for PCR amplification of a
complete repeat unit meant that amplification products were
90 and 91 bp, respectively. Only one variation was seen in the
DNAs (Fig. 3). That is, whereas blue plaque isolates gave a
product containing a C6 sequence from the repeat units, white
plaque-derived materials had a C7 sequence. The ratio of C6 to
C7 found in the Daudi 90- and 91-bp products was 7:1 in
uninduced and 9:1 in chemically induced cells. This differ-
ence, probably not significant, implies that the frameshifts gen-
erally observed in LF3 are independent of chemical induction.
Several clones were found to have multiple inserts. Interest-
ingly, one of these contained two 90-bp (C6) sequences, but
another had one 90-bp (C6) and one 91-bp (C7) IR 4 sequence.
Whereas direct sequencing of 5 and 3 residues (Table 1 and
TABLE 1. Oligopyrimidine sequences at the 5 and 3 frameshift
variable regions in the LF3 gene and repeat copy numbers
from different sourcesa
EBV strain (repeat copy no.) 5-endsequence
3-end
sequence Pattern
C15 (22.7) CCCCCC CCCCCC 1
C17 (27.7) CCCCCC CCCCC 2
C18 (24.7) CCCCCC CCCCCC 1
NPC 1 (23.7) TCCCC CCCCCC 3
NPC 2 (22.7) TCCCC CCCCCC 3
M-ABA	 (25.7) TCCC CCCCC 6
Raji	 (24.7) TCCCC CCCCC 4
Daudi-ICRF/ATCC	 (23.7) TCCCC CCCCCC 3
Daudi 100K	 (ND) TCCCC CCCCCC 3
P3HR-1	 (21.7, 25.7) CCCCCC CCCCCC 1
BL-74	 (25.7) TCCCC CCCCCC 3
BL-001 (28.7) TCCCC CCCCC 4
BL-002 (24.7) TCCCC CCCCC 4
BL-003 (24.7) TCCCC CCCCC 4
BL-004 (24.7) TCCCC CCCCC 4
BL-005 (29.7) TCCCC CCCCC 4
BL-006 (33.7) TCCCC CCCCCC 3
BL-007 (29.7) TCCCC CCCCC 4
BL-SD (28.7) TCCCC CCCCC 4
BL-IB (23.7) TCCCC CCCCC 4
M81 (ND) TCCCC CCCCCC 3
a All cells except M81, a marmoset line, were from human sources. ND, not
done. , xenografts from North African NPCs. , Chinese NPC biopsies. 	, cell
lines from African Burkitt’s lymphomas (BLs). , BL biopsies. Combinations of
sequences are designated, respectively: 5-C6 with 3-C6 or C5, 1 and 2; 5 TC4
with 3-C6 or C5, 3 and 4; 5-TC3 with 3-C6 or C5, 5 and 6. Only combination
patterns 1 and 6 with nucleotide numbers (n  12 or 9) divisible by 3 are
predicted to have initiation and termination codons in the same reading frames
in their transcripts and thus accommodate a protein (see Fig. 2).
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Fig. 2) had failed to identify any C7 product from the Daudi
cells, this cloning technique showed its existence. By this tech-
nique, however, we did not identify its precise internal location
in the gene. Notably, however expansion from C6 to C7 in an
internal repeat in Daudi cells would shift it from pattern 3 to
a pattern 1 profile (Fig. 2) and permit protein expression.
Frameshifting is independent of the number of IR 4 repeats
in the LF3 gene in different cells. For eukaryotic cells, it has
been observed that when replication frameshifts involve reit-
erated sequences, the number of potential misaligned interme-
diates and correct base pairs that can stabilize such misalign-
ments increases as the length of the run increases (21). To ask
FIG. 2. Predicted translation products from LF3 transcripts. The sequence shown is that corresponding to the stable mature LF3 RNAs from different
sources (see Table 1), which generate protein data (as given) that are predicted from particular sequences obtained by combining those identified
in the framshift variable regions at the 5 and 3 ends of the genome (bold type). Deletions generated by frameshifting events at the 5 and 3 ends
are indicated (). Given here (dashed line between arrowheads) are two complete and one partial (0.7) IR 4 repeat sequences as found in different
LF3 genes. Also shown (underlined) are the PstI (CTGCAG) restriction sites which allow single repeat copies, the source of previous sequence
data (5, 11, 23, 30, 43), to be excised from the gene, and the first termination codon (TGA, also see Fig. 1) and the polyadenylation (AATAAA)
signal. Notably, multiple termination codons (in italics) are all in the same coding frame, and the single AATAAA is used for maturation of all
LF3 transcripts. As indicated (patterns 2 to 5), the initiation (ATG) and termination codons may not lie in the same reading frame. Depending
upon the reading frame translated (as determined by 5- and 3-end combination patterns, designated 1 to 6, see Table 1), the LF3 protein in two
of three cases would contain aspartic acid-proline (DP) regions, which are predictably sensitive to enzyme degradation at acidic pH conditions.
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whether repeat copy numbers might correlate with the ob-
served slippage patterns of LF3, the numbers of IR 4 repeats
from different EBV strains was determined, with a technique
described previously (30). In each case examined (see Table 1),
except for uncloned P3HR-1, where two copy number variants
(n  21.7 and n  25.7) were found, each cell line had its own
repeat copy number. These ranged from 21.7 to 33.7, indicat-
ing a potential difference of up to 408 amino acids in LF3
proteins from different sources. (The 0.7 represents the 3-
most incomplete repeat, shown in Fig. 2.) Unlike reports from
studies on microsatellites (reviewed in reference 39), where
replication errors resulted in copy number variations, we saw
no correlation between repeat numbers and sequence speci-
fied, as best illustrated by the African Burkitt’s lymphoma
biopsies. Thus, whereas repeat copy numbers may be of rele-
vance, no biological significance was apparent in this study.
LF3 protein expression. Sequence variations might be of
little consequence if LF3 were an untranslated gene whose
function, if any, lay in its RNA (see reference 37 for discussion
of this topic). However, as argument against this notion, not
only is the primary transcript of LF3 polyadenylated, but pro-
teins have been identified in several B-cell lines (29). Since
determining frameshifts within all internal repeats is difficult
by sequencing methodologies, protein structures of LF3 in
individual cells or tumors cannot be predicted by such meth-
ods. Protein data may be highly relevant, however, to under-
standing the cellular selective pressures that lead to the frame-
shift mutational events. However, identification of proteins
from the LF3 gene has also proved problematic. As noted
earlier, for example, whereas in M-ABA cells one group (29)
identified a protein, another (23) did not, and in our hands
detection of proteins from a single cell type, such as M-ABA or
P3HR-1, did not always give reproducible results (data not
shown).
In the light of the gene sequence data (Table 1, Fig. 2 and 3),
a polyclonal antibody generated from a recombinant clone that
expressed 46 amino acids of the C-terminal part of the protein
in M-ABA cells (N. Mueller-Lantzsch, personal communica-
tion), often used in experiments aimed at examining LF3 pro-
tein expression, may be suboptimal for protein assays in other
cells. This antibody did, however, allow detection of a protein
where none is predicted (Fig. 2) in the Burkitt’s lymphoma-
derived line BL74 (29) and in Daudi-ICRF cells (44), support-
ing further the notion of frameshifts within internal repeats.
We used the antibody to probe Western immunoblots of
proteins extracted from several other cell lines and controls,
with and without chemical induction, and from the C15 NPC
xenograft. Full-length proteins of expected sizes (Fig. 4A) were
identified in Daudi-ICRF and its mutant variant Daudi-100K,
in M-ABA cells, and in the EBV producer lines P3HR-1 and
BL74. For C15, although the repeat copy number of LF3 is at
the lower end of the range (22.7 copies, Table 1), the discrete
protein band observed was only half its expected size. No
proteins of expected sizes were observed for Raji and M81
cells. Since chemical induction was an important factor in
allowing a protein to be identified (29; our data) but appeared
to have little effect on frameshifting, this finding may merely
reflect the increased mRNA levels found in induced cells (11).
Figure 4A represents data from two Western blots which
differed only in that whereas inexplicably in one experiment no
protein was observed with M-ABA cells, in another experiment
(as shown), in induced cells, full-length and shorter polypep-
tides were observed. Reproducibly, in the C15 NPC tumor,
only a shorter (stable) polypeptide was ever observed. Since
levels are low, our Western blot data (Fig. 4A) used cytoplas-
mic extracts from cells, which proved superior to whole cell
extracts for protein analysis. In addition, they revealed
polypeptide patterns not explicable by sequence frameshifts,
but indicative of another level of degeneracy for LF3: in addi-
tion to full-length proteins, numerous smaller polypeptide
bands with integrals of about 34 amino acids (equivalent to a
102-bp repeat) were also observed in materials from Daudi-
ICRF, P3HR-1, and M-ABA cells, although inexplicably not
from the chemically mutated Daudi-ICRF 100K line (36) or
from BL74.
To evaluate protein expression further, antibodies were
raised to peptides (designated PP, PR, and PA, from the first
unique dipeptide in different reading frames, see Fig. 2) from
the three internal repeat elements. With these antibodies and
induced Daudi-ICRF cells, specific immunoreactive polypep-
tides were observed with PR (Fig. 4B) or PP but not with PA
(not shown), induction being required (as in Fig. 4A) to ob-
serve the protein. With P3HR-1 cells, the PP antibody recog-
nized a full-length discrete protein and smaller species in cells
with or without induction (Fig. 4B). The data are consistent
with findings given in Fig. 2 and 3. From both cells the polypep-
tide bands were notably strong. That the degraded bands were
not so sharp for P3HR-1 as they were for Daudi-ICRF may
reflect the fact that with regard to numbers of repetitive se-
quences, P3HR-1 is a mixed population of cells (Table 1).
Again, the data support the hypothesis of internal frameshifts
within the LF3 gene. The polypeptide degeneracy in products
from some sources, which cannot be explained by frameshift
mutations, raises the possibility that in the highly structured
RNA from LF3 (12) either slippages are taking place on the
ribosome during translation or that, in some cases, specific
protein degradation is occurring.
FIG. 3. Slippage events in internal IR 4 repeats. Partial sequence
profiles (see Fig. 2) in 102-bp (blue plaque) and 103-bp (white plaque)
recombinant DNA repeats from Daudi-ICRF isolates. C6 and C7 se-
quences (bold type) were obtained from the same cell isolate and were
the only sequence alterations found in the Daudi repeats, whether
from chemically induced or uninduced cells.
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Immunostaining of cells for LF3 protein give data consis-
tent with genetic diversity. To examine on a single cell basis
whether chemical induction leads to large amounts of protein
being generated in a small number of cells, or vice versa,
immunostaining experiments were carried out. Such studies
were also relevant for confirming the subcellular location of
the LF3 translation product and whether it resides largely in
the cytoplasm, as suggested by Western blot results, or might
also be localized in the nucleus, in accordance with a role in
DNA replication (13). For these studies, EBV-positive cell
lines M-ABA, M81, and Burkitt’s lymphoma-derived cell lines
Raji, Daudi-ICRF, BL74, and P3HR-1 were used, both with
and without induction, with Ramos (EBV negative) and B95-8
cells (with an LF3 deletion) as controls.
Data given in Fig. 5A show that whereas the low-virus-
producer cell line M81 had appeared negative for expression of
the LF3 protein on Western blots (Fig. 4A), on immunostain-
ing following induction, small numbers of cells with low levels
of fluorescence were observed. No expression was seen in Raji
(or B95-8) cells. From immunostaining data, the LF3 protein
FIG. 4. Western blots of LF3 proteins. (A) LF3 polypeptides from cytoplasmic extracts of cells propagated in the absence () or presence ()
of the chemical inducing agents tetradecanoyl phorbol acetate and n-butyrate and identified with a rabbit polyclonal antibody from M-ABA cells
(29). Sizes of protein markers are given on the right. Arrows indicate sizes predicted for full-length proteins from different sources or degraded
residues with different numbers of repetitive (about 34 amino acids) sequences. No polypeptide ladders were observed in three cases, Daudi-100K,
BL74, and C15, but in the last, the product was roughly half its expected size. No bands of the expected size were observed in Raji and M-81 cells
(as predicted, Table 1 and Fig. 2). The data for M-ABA were taken from a separate Western blot. (B) Proteins from cytoplasmic extracts of
Daudi-ICRF or P3HR-1 uninduced () and induced () cells (panels 2 and 4, respectively) stained with polypeptide antibody PR or PP, as noted,
or with the corresponding preimmune serum samples (panels 1 and 3). Positions of protein size markers (lane M) are indicated on the right of
each panel, and integrals suggesting loss of a repeat polypeptide are indicated on the left. In the case of Daudi cells, induction was required for
protein detection, whereas this was not so with P3HR-1.
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appears in detectable amounts in a subpopulation of cells only
(at most 10%), expression being generally enhanced upon
chemical induction and more prominent in the cytoplasm than
in the nucleus. An example of cytoplasmic (panel a) and nu-
clear (panel b) staining patterns in P3HR-1 cells is shown in
Fig. 5B, where in the latter the stained cells appear to be in
mitosis. Overall, the protein data accord with the genetic data.
DISCUSSION
Viruses, noted for the mechanisms that they adopt to in-
crease their coding capacities and ensure survival, have also
proved good models for events that can also occur in their
hosts. The large DNA viruses (herpesviruses and poxviruses)
are particularly adept in vivo at adapting to the immunological
status of their host (1). We suggest that the latter may account
for the frameshifting events we observe with the unusual LF3
gene of the oncogenic EBV. Such events lead to a demonstra-
bly high degree of genetic variation.
LF3 contains only a small amount of unique sequence, the
bulk of its information residing in multiple copies (Table 1) of
a mainly 102-bp GC-rich repeat, designed IR 4. It is found
transcriptionally expressed in a variety of virally infected cell
lines and tumors (8, 11, 12, 43, 45). Its protein product has
been postulated to be associated with productive expression of
EBV (29), and in our studies, without the use of chemical
inducing agents, protein was detected only in a cell line
(P3HR-1) that can spontaneously generate virus. The frame-
shifts observed occur at short runs of pyrimidines (mainly cy-
tidines) found throughout the gene. Sequence data, as illus-
trated in Fig. 2, support the need for frameshifting events to
occur in order to generate a protein in some cells, and molec-
ular (Fig. 3) and immunofluorescence (Fig. 5) data suggest that
this occurs in a minority of cells only (10% or fewer) in most
isolates. Notably, most EBV-infected cells do not spontane-
ously produce virus. LF3 is probably not unique to EBV in that
a gene similar to it has been predicted to exist in the recently
sequenced rhesus lymphocryptovirus (34), and it is worth keep-
ing an open mind with regard to the possibility that among the
many repetitive sequences in the human genome, one or more
might well have properties similar to those found for LF3.
In normal eukaryotic cells, although DNA replication fidel-
ity is exceedingly high, not all of the enzyme components in-
volved in replication have proofreading-associated functions.
Structural elements that promote stable frameshifts have been
defined in part as those, like LF3, which contain a high fre-
quency of reiterated (including homopolymer) sequences and
tandem repeats (6). For LF3 as well, its high GC content
(85%) could make it vulnerable and subject during replica-
tion to aberrant mispairing or replication complex stuttering
mechanisms that contribute to slippage events (21, 24, 41).
Coupling these data with the fact that malfunctions of mis-
match repair processes occur in tumors (18), with hindsight it
is probably not surprising that, consistent with molecular hy-
bridization and translational data (11, 43, 45), variation in the
sequence of this viral gene in different cell isolates occurs. We
propose that sequence frameshifts in LF3, having occurred
initially at the DNA level in short runs of pyrimidines, reflect
DNA polymerase slippage and its failure of correction, rather
than internal recombination events - since it seems unlikely
FIG. 5. Immunostaining of LF3 proteins. (A) Cells propagated
without () or with () chemical inducing agents and stained with
preimmune serum (vertical column 1) or with antibody (columns 2 and
3) from recombinant M-ABA polypeptide (29). Only in P3HR-1 (hor-
izontal panels 6) were stained cells observed without chemical induc-
tion (see also Fig. 4). By this technique, all other isolates examined
(except the B95-8 control and Raji), including M81, show small num-
bers of positively (mainly cytoplasmic) stained cells following chemical
induction. Preimmune serum samples gave negative results. (B) Cyto-
plasmic and nuclear staining of LF3 protein in P3HR-1 induced cells,
photographed by confocal microscopy. Panel a shows a cell with cyto-
plasmic staining, and panel b shows cells with nuclear staining. These
data demonstrate that the protein can reside at two cellular sites and
belongs to the early antigen-diffuse family of EBV proteins. Examina-
tion of larger fields of cells (not shown) indicated that cytoplasmic
staining predominated. Similar conclusions were reached from West-
ern blot data on Daudi-ICRF and M-ABA cell isolates.
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that the latter would be sufficiently promiscuous to allow for all
the variables in sequence observed or predicted (Table 1 and
Fig. 2) and account for the apparent genetic diversity observed.
The occurrence of frameshifting events in a gene consisting of
repeats usually divisible by three theoretically allows expres-
sion of a unique protein in virally infected cells from any
particular source, depending upon the repeat copy numbers in
the gene and the sites at which mutations occur.
There are other unusual aspects to this gene. Western blots
earlier identified proteins from LF3 that varied between 115 to
140 kDa, depending (presumably) on its repeat copy number in
an individual cell (29). Two other things were noted in this
cited work that are relevant to our findings and support protein
diversity. One was that only a small fraction of human serum
samples (4 of 57) that were positive for EBV early and late
antigens also recognized the recombinant LF3 protein from
M-ABA cells. The other was that protein derived from a re-
combinant construction containing the whole LF3 gene, ex-
pressed in E. coli, was rapidly degraded; only a protein con-
siderably reduced in size (by removal of most of the repetitive
sequences), as seen in the C15 NPC tumor (Fig. 4A), proved
stable.
Our Western blot data (Fig. 4) with a single antibody (29)
point to another aspect of diversity, epitomized by specific
degradation of the protein, with integrals of about 34 amino
acids in some (but not all) cells. In M-ABA, P3HR-1, and
Daudi-ICRF cells, ladders extending from a predicted full-
sized peptide to much smaller peptides (
40 kDa) were ob-
served, whereas the chemically modified Daudi-100K and
BL74 cells produced mainly a full-sized protein and the NPC
xenograft C15 gave a truncated (about half the predicted size)
stable protein; with polypeptide antibodies made from differ-
ent repeat sequences (see Materials and Methods and Fig. 2),
cytoplasmic extracts from Daudi-ICRF and P3HR-1 cells gave
similar ladders. Notably here, in line with sequence data, one
polypeptide antibody proved more responsive in the first case
and another in the second (Fig. 4B).
Although slippages on the ribosome during translation, such
as postulated for some RNA and RNA viruses (31, 42, 46) but
not reported for transcripts from DNA viruses, might account
for the protein diversity, it seems an unlikely mechanism to
explain the degradation products observed. From different cell
sources, the transcription products of LF3 generally represent
point mutations only, and their sequences are not apparently
influenced by the repeat copy number in a particular cell. An
alternative explanation for the polypeptide ladders seen may
be suggested by sequences within the repeats themselves, in
that two of the three LF3 coding frames contain rare aspartic
acid-proline (DP) dipeptides (Fig. 2), known to be susceptible
to acid degradation. In vitro, the conditions for this specific
degradation are quite drastic, low pH and high temperature
(33), and not commensurate with the data shown in Fig. 4.
Thus, the observed degradations do not seem wholly explain-
able by pH changes during cell culture or isolate work-up. They
might occur, however, if the proteins were targeted to lyso-
somes, where they would encounter not only sustained low-pH
conditions but also numerous acid hydrolases, such as those
suggested to be used for specific enzymatic degradation of a
salivary gland protein (10).
There is no evidence of a lysosome-targeting signal in LF3
proteins, and at this stage in our work, although we have
evidence for the cytosolic location of the majority of the LF3
protein expressed (Fig. 5), we cannot comment on its specific
localization. Notably the degradative process has specificity (as
predicted, Fig. 2) and is not equally effective on all LF3 pro-
teins (see those from the chemically modified 100K protein
from Daudi-ICRF cells or the tumor-derived line BL74). The
protein in the C15 xenograft may also have largely evaded the
degradative pathway by losing most of its repeats. In the rhesus
lymphoproliferative virus (34), the LF3 homologue identified
should also have DP sequences in two out of its three coding
frames, raising interesting questions about an apparently con-
served protein function between these viruses.
In the work presented here, we have examined LF3 not
because of its putative role in lytic DNA replication, but with
regard to its notable genetic diversity. There may be a corre-
lation between these topics. LF3 is strategically placed to play
an important, possibly initiating role in lytic replication (8, 11,
13), being located adjacent to one of the two EBV lytic origins
of replication, both of which contain AT-rich palindromic el-
ements and a large homopurine-homopyrimidine tract that
could adopt a classical triple-helical hinge and single-stranded
DNA regions (11). Such structures conform to those found in
replication origins of other DNA viruses (7), where suscepti-
bility to mutations, above background levels, has been reported
to occur during replication (35). As elsewhere (41), they allow
polymerase pauses to occur during DNA replication, with dis-
sociation of the enzyme and ultimate induction of slippage.
Our findings raise questions about selective pressures that
give rise to the diversities that define LF3, both with regard to
the gene and its protein, where a ’tug-of-war’ between the virus
and its host may take place. Chemical inducing agents, well
known to support lytic replication of EBV, can influence the
outcome. The frameshifting events themselves may be a sur-
vival stratagem of the virus, allowing it to produce a potentially
immunogenic protein in some hosts but to evade the immune
system and proliferate in others, that is, generate a viral de-
fense mechanism. Destroying the viral protein in the absence
of an effective immune mechanism by targeting it to a pathway
where it can be degraded may reflect a host defense mecha-
nism (1). The phenomena observed with LF3 merit further
investigation not just with regard to virus-host interactions, but
also for the light they might shed on cellular repetitive ele-
ments, often relegated to the status of junk DNA.
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